Bosutinib 500 mg Tablet

Bosutinib 500 mg Tablet – Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia (CML)

Bosutinib 500 mg Tablet contains Bosutinib 500 mg, a prescription anticancer medication used for the treatment of Philadelphia chromosome-positive (Ph+) Chronic Myeloid Leukemia (CML) in adults. It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking abnormal proteins that promote the growth and spread of leukemia cells. Bosutinib helps slow or stop the growth of cancer cells and may be used as first-line therapy or in patients who have not responded adequately to or cannot tolerate certain other CML treatments. Treatment should always be supervised by an experienced oncologist. Take Bosutinib 500 mg Tablet exactly as prescribed by your healthcare professional. Regular blood tests and medical monitoring are essential during treatment to evaluate response and detect possible side effects.

Key Features

• Contains Bosutinib 500 mg: A targeted tyrosine kinase inhibitor for CML treatment.
• Treats Philadelphia Chromosome-Positive CML: Helps control the progression of leukemia.
• Targeted Cancer Therapy: Blocks abnormal BCR-ABL tyrosine kinase activity.
• Once-Daily Oral Tablet: Convenient dosing as prescribed by your oncologist.
• Supports Long-Term Disease Management: Helps improve treatment outcomes when taken consistently.

Active Ingredient

• Bosutinib 500 mg: A tyrosine kinase inhibitor used for the treatment of Philadelphia chromosome-positive Chronic Myeloid Leukemia.

How to Use

• Take the tablet exactly as prescribed by your healthcare provider.
• Swallow the tablet whole with water.
• Take it with food at the same time each day.
• Do not crush, chew, or split the tablet.
• Do not stop treatment unless instructed by your oncologist.

Precautions

• Use only under the supervision of a qualified oncologist.
• Regular blood tests and liver function monitoring may be required during treatment.
• Inform your doctor if you have liver disease, kidney disease, heart problems, or any other serious medical condition.
• Avoid grapefruit and grapefruit juice unless advised otherwise by your healthcare provider.
• Inform your doctor about all medications, vitamins, and herbal supplements you are taking.

Warning

• Common side effects may include diarrhea, nausea, vomiting, abdominal pain, fatigue, rash, headache, and decreased blood cell counts.
• Seek immediate medical attention if you develop signs of infection, unusual bleeding, severe liver problems, chest pain, or difficulty breathing.
• This medicine may cause harm to an unborn baby. Effective contraception should be used during treatment if recommended by your healthcare provider.
• Use only as directed by your oncologist.

Storage

• Store below 30°C in a cool, dry place.
• Protect from moisture, heat, and direct sunlight.
• Keep the tablets in their original packaging until use.
• Keep out of reach of children.

Legal Disclaimer: Bosutinib 500 mg Tablet is a prescription anticancer medication intended for the treatment of Philadelphia chromosome-positive Chronic Myeloid Leukemia (CML). It should only be used under the supervision of a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.